Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hepatitis

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    April 2024
  1. KARTSONAKI C, Yao P, Butt J, Jeske R, et al
    Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
    Int J Cancer. 2024;154:1423-1432.
    PubMed     Abstract available


    January 2024
  2. ZHAO G, Shi X, Zhang L, Liang H, et al
    Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
    Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34796.
    PubMed    


  3. KIM MN, Zhang X, Ahn SH
    Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
    Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34797.
    PubMed    


    August 2023
  4. HA Y, Lim J, Chon YE, Kim MN, et al
    Five-year on-treatment variables-based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir-treated patients.
    Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34704.
    PubMed     Abstract available


    July 2023
  5. KIM MN, Han K, Yoo J, Hwang SG, et al
    Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients.
    Int J Cancer. 2023 Jul 13. doi: 10.1002/ijc.34637.
    PubMed     Abstract available


    May 2023
  6. ZENG D, Fang Y, Fei Y, Liang R, et al
    Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
    Int J Cancer. 2023 May 19. doi: 10.1002/ijc.34565.
    PubMed     Abstract available


    March 2023
  7. PETRICK JL, Florio AA, Zen J, Wang Y, et al
    Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV Cohort Studies.
    Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34492.
    PubMed     Abstract available


    July 2022
  8. FU P, Gong B, Li H, Luo Q, et al
    Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
    Int J Cancer. 2022 Jul 8. doi: 10.1002/ijc.34201.
    PubMed     Abstract available


    May 2022
  9. LIU T, Shi H
    Reply to: Comment on "Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study".
    Int J Cancer. 2022 May 10. doi: 10.1002/ijc.34113.
    PubMed    


  10. YANG Y, Chen XZ
    Comment on: "Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study".
    Int J Cancer. 2022 May 10. doi: 10.1002/ijc.34114.
    PubMed    


    April 2022
  11. CHEN S, Gao Y, Wang Y, Daemen T, et al
    The Combined Signatures of Hypoxia and Cellular Landscape Provides a Prognostic and Therapeutic Biomarker in HBV-Related Hepatocellular Carcinoma.
    Int J Cancer. 2022 Apr 25. doi: 10.1002/ijc.34045.
    PubMed     Abstract available


    December 2021
  12. LIU T, Song C, Zhang Y, Siyin ST, et al
    Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study.
    Int J Cancer. 2021 Dec 2. doi: 10.1002/ijc.33891.
    PubMed     Abstract available


    June 2021
  13. JI XW, Wang J, Shen QM, Li ZY, et al
    Dietary fat intake and liver cancer incidence: A population-based cohort study in Chinese men.
    Int J Cancer. 2021;148:2982-2996.
    PubMed     Abstract available


  14. YU C, Song C, Lv J, Zhu M, et al
    Prediction and clinical utility of a liver cancer risk model in Chinese adults: A prospective cohort study of 0.5 million people.
    Int J Cancer. 2021;148:2924-2934.
    PubMed     Abstract available


  15. JAQUET A, Boni SP, Boidy K, Tine J, et al
    Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
    Int J Cancer. 2021 Jun 14. doi: 10.1002/ijc.33709.
    PubMed     Abstract available


    March 2021
  16. SHI JF, Cao M, Wang Y, Bai FZ, et al
    Is it possible to halve the incidence of liver cancer in China by 2050?
    Int J Cancer. 2021;148:1051-1065.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.